TWST
Twist Bioscience Corporation · Healthcare · Medical - Diagnostics & Research
Input momentum (manajer yang sebanding):
keluasan pemegang +6.7% ·
aliran saham +3.7% ·
posisi baru bersih +6.2%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q1 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 113 | +8 | 54.74M | $5.63B | +14 | −6 |
| Q1 2026 | 108 | +15 | 51.20M | $2.43B | +20 | −5 |
| Q4 2025 | 92 | -2 | 51.46M | $1.63B | +1 | −3 |
| Q3 2025 | 18 | 0 | 32.97M | $927.70M | +1 | −2 |
| Q2 2025 | 16 | -3 | 28.73M | $1.06B | — | −3 |
| Q1 2025 | 16 | +1 | 15.75M | $618.44M | +2 | −1 |
| Q4 2024 | 15 | 0 | 15.20M | $706.21M | — | — |
| Q3 2024 | 14 | +1 | 11.38M | $514.14M | +2 | −1 |
| Q2 2024 | 13 | — | 12.61M | $621.59M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 6.24M | +11.5% | $245.05M | 2.5% | ▲ Add | 4 | SEC ↗ |
| 2 | State Street Global Advisors ✦ (pasif) | 2.69M | +5.9% | $105.75M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Point72 Asset Management ✦ | 1.43M | Baru | $56.25M | 0.2% | New | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasif) | 1.42M | +3.3% | $55.76M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 5 | Citadel Advisors ✦ | 1.07M | -23.6% | $42.06M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 760.95K | -3.2% | $29.87M | 0.0% | ▼ Trim | 4 | SEC ↗ ×5 |
| 7 | Baillie Gifford ✦ | 732.01K | -5.9% | $28.74M | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 8 | Marshall Wace ✦ | 318.19K | -62.4% | $12.49M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 9 | Millennium Management ✦ | 308.22K | -51.4% | $12.10M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 265.65K | +65.2% | $10.43M | 0.0% | ▲ Add | 4 | SEC ↗ ×5 |
| 11 | Renaissance Technologies ✦ | 193.91K | -51.4% | $7.61M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Two Sigma Investments ✦ | 140.68K | -59.5% | $5.52M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 13 | Norges Bank ✦ (pasif) | 82.38K | -49.5% | $3.23M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | T. Rowe Price ✦ | 45.76K | +10.5% | $1.80M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 15 | Fisher Asset Management ✦ | 39.41K | Baru | $1.55M | 0.0% | New | 1 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 5.69K | -94.7% | $223,350 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Point72 Asset Management | $56.25M | 0.2% |
| Fisher Asset Management | $1.55M | 0.0% |
Telah keluar
| Gotham Asset Management | $786,505 | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 279 pemegang, 76.80M saham, $3.56B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer · 2.46K lbr · $384,823
Officer, Director · 45 lbr · $9,336
Officer, Director · 146 lbr · $30,199
Officer, Director · 297 lbr · $61,116
Officer, Director · 290 lbr · $59,392
Officer, Director · 432 lbr · $87,958
Officer, Director · 1.02K lbr · $205,763
Officer, Director · 1.84K lbr · $368,806
Officer, Director · 481 lbr · $96,804
Officer · 25.71K lbr · $4.86M
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi